Previous studies have highlighted COL1A1, YAP1 and chemokine receptor CXCR4 as targets of RUNX2 that facilitate the in vitro invasion and metastatic potential of gastric cancer cells (4, 7). This evidence concerns the gene CXCR4 and gastric cancer.